CLINICAL-PHARMACOLOGY AND TOXICOLOGY OF COCAINE

被引:158
作者
BENOWITZ, NL
机构
[1] UNIV CALIF SAN FRANCISCO, DIV CLIN PHARMACOL & EXPTL THERAPEUT, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA
[3] UNIV CALIF SAN FRANCISCO, DEPT PSYCHIAT, SAN FRANCISCO, CA 94143 USA
来源
PHARMACOLOGY & TOXICOLOGY | 1993年 / 72卷 / 01期
关键词
D O I
10.1111/j.1600-0773.1993.tb01331.x
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Cocaine abuse has produced a major epidemic health problem in North America in the 1980s. The abuse of cocaine is maintained by the drug's effects on brain reward systems, mediated at least in part by its dopaminergic action. The patterns and consequences of use are best understood by considering the pharmacokinetics (rapid absorption and delivery to the brain, relatively short half-life) and the pharmacodynamics (intense central and peripheral neural stimulation). Cocaine is used therapeutically as a topical and local anaesthetic. Toxicity occurs primarily in cocaine abusers, but also occasionally after therapeutic dosing. Medical complications reflect primarily excessive central nervous system stimulation and excessive vasoconstriction, the latter resulting in severe hypertension and/or organ ischaemia with associated organ injury. Most deaths that result from medical complications of cocaine intoxication are sudden and occur before medical intervention is possible. Other complications of cocaine abuse with severe personal and social consequences include traumatic deaths and injuries, and reproductive disturbances, as well as transmission of infectious diseases, especially AIDS. Cocaine addiction is clearly a problem, although the number of addicts is unknown. Pharmacologic treatment of cocaine addiction has as yet been unsuccessful. Psychosocial approaches remain the mainstay of therapy.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 83 条
[2]
ACUTE TOLERANCE TO COCAINE IN HUMANS [J].
AMBRE, JJ ;
BELKNAP, SM ;
NELSON, J ;
RUO, TI ;
SHIN, SG ;
ATKINSON, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) :1-8
[3]
NEW EVIDENCE ON INTRAVENOUS COCAINE USE AND THE RISK OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
ANTHONY, JC ;
VLAHOV, D ;
NELSON, KE ;
COHN, S ;
ASTEMBORSKI, J ;
SOLOMON, L .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (10) :1175-1189
[4]
BATKI SL, 1991, PROBLEMS DRUG DEPEND, P516
[5]
HEMODYNAMIC AND ELECTROPHYSIOLOGICAL ACTIONS OF COCAINE - EFFECTS OF SODIUM-BICARBONATE AS AN ANTIDOTE IN DOGS [J].
BECKMAN, KJ ;
PARKER, RB ;
HARIMAN, RJ ;
GALLASTEGUI, JL ;
JAVAID, JI ;
BAUMAN, JL .
CIRCULATION, 1991, 83 (05) :1799-1807
[6]
BENOWITZ NL, 1992, CIBA F SYMP, V166, P125
[7]
BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
[8]
COCAINE-RELATED MEDICAL PROBLEMS - CONSECUTIVE SERIES OF 233 PATIENTS [J].
BRODY, SL ;
SLOVIS, CM ;
WRENN, KD .
AMERICAN JOURNAL OF MEDICINE, 1990, 88 (04) :325-331
[9]
BROWN EE, 1991, J PHARMACOL EXP THER, V256, P119
[10]
CHASNOFF IJ, 1987, PEDIATRICS, V80, P836